Pain Syndrome Clinical Trial
Official title:
The Effects of Jing Si Herbal Tea on Physical and Psychological Symptoms in Peripheral Blood Hematopoietic Stem Cell Donors
Verified date | November 2023 |
Source | Buddhist Tzu Chi General Hospital |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
This study aim to explore the impact of Jing Si Herbal Tea on pain and emotional stress in peripheral blood stem cell donors.
Status | Not yet recruiting |
Enrollment | 80 |
Est. completion date | December 31, 2024 |
Est. primary completion date | December 31, 2024 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 20 Years to 55 Years |
Eligibility | Inclusion Criteria: - health Men or women aged 20 to 55 years old - willing to take Jing Si Herbal Drink Exclusion Criteria: - no willing to take Jing Si Herbal Drink; - Previously already take Jing Si Herbal Drink daily |
Country | Name | City | State |
---|---|---|---|
n/a |
Lead Sponsor | Collaborator |
---|---|
Buddhist Tzu Chi General Hospital |
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Changes in pain assessed by questionnaires | For each of the pain sites includes: headache?bone?joint & muscle, indicate the severity of present using the following scale (baseline vs. follow-up).
grade 0: fully active, able to carry on all pre-disease performance without restriction grade 1: restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g. light housework, office work grade 2: ambulatory and capable of all self-care but unable to carry out any work activities, up and about more than 50% of waking hours grade 3: capable of only limited self-care, confined to bed or chair more than 50% of waking hours grade 4: completely disabled, cannot carry on any self-care, totally confined to bed or chair grade 5: dead |
5 day | |
Secondary | Changes in anxiety assessed by questionnaires | Difference in donor Health State Trait Anxiety Index (STAI) scores (baseline vs. follow-up).
The STAI questionnaire consists of 20 items for assessing "state anxiety" and 20 items for assessing "trait anxiety," with a raw score of 20 to 60 points for each scale. The state anxiety scale evaluates the current state of anxiety associated with a special situation, measuring subjective feelings of apprehension, tension, nervousness, worry, and activation of the autonomic nervous system, whereas the trait anxiety scale evaluates proneness to anxiety . The level of anxiety was determined according to the percentile rank obtained using the raw score of each questionnaire and was classified as low anxiety (1st-23th percentile), moderate anxiety (25th75th percentile) and high anxiety (77th-99th percentile). |
21 days |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03793790 -
The Role of Learning in Nocebo Hyperalgesia
|
N/A | |
Completed |
NCT04527770 -
Midazolam Versus Dexamethasone as an Adjuvant to Local Anesthetics in the Ultrasound Guided Hydrodissection of Median Nerve for Treatment of Carpal Tunnel Syndrome Patients
|
N/A | |
Recruiting |
NCT03859089 -
Cannabis for Opioid Substitution Trial
|
||
Withdrawn |
NCT03707444 -
A Pilot Trial of Scrambler Therapy for Pain Associated With Pancreas Cancer
|
||
Recruiting |
NCT03498976 -
RFp on Suprascapular N. Versus RFp on Suprascapular N. and Circumflex in the Treatment of Painful Shoulder
|
N/A | |
Recruiting |
NCT04299893 -
Ozone Therapy in Chemotherapy-induced Peripheral Neuropathy: RCT (O3NPIQ)
|
Phase 2/Phase 3 | |
Completed |
NCT04625504 -
Investigating Biological Targets, Markers, and Intervention for Chronic Pain
|
N/A | |
Recruiting |
NCT06071949 -
Efficacy and Tolerability of AP707 in Patients With Chronic Pain Due to Central Neuropathy of Any Genesis
|
Phase 3 | |
Recruiting |
NCT06071962 -
Long Term Efficacy and Tolerability of AP707 in Patients With Chronic Back Pain
|
Phase 3 | |
Recruiting |
NCT06072001 -
Long Term Efficacy and Tolerability of AP707 in Patients With Chronic Pain Due to Central Neuropathy of Any Genesis
|
Phase 3 | |
Recruiting |
NCT06071988 -
Long Term Efficacy and Tolerability of AP707 in Patients With Chronic Pain Due to Traumatic or Post-operative Peripheral Neuropathy
|
Phase 3 | |
Recruiting |
NCT06072560 -
Efficacy and Tolerability of AP707 in Patients With Chronic Back Pain
|
Phase 3 | |
Recruiting |
NCT06071975 -
Long Term Efficacy and Tolerability of AP707 in Patients With Chronic Pain Due to Diabetic Polyneuropathy
|
Phase 3 | |
Recruiting |
NCT06071936 -
Efficacy and Tolerability of AP707 in Patients With Chronic Pain Due to Traumatic or Post-operative Peripheral Neuropathy
|
Phase 3 | |
Recruiting |
NCT06072573 -
Efficacy and Tolerability of AP707 in Patients With Chronic Pain Due to Diabetic Polyneuropathy
|
Phase 3 | |
Completed |
NCT05811455 -
Comparative Effects of Aerobic Exercises and Progressive Muscle Relaxation Exercises on Pain and Quality of Life
|
N/A | |
Completed |
NCT03755817 -
Efficacy Assessment of SCENAR Device on Common Spinal Pain Syndrome
|
N/A | |
Completed |
NCT06010381 -
Muscle Energy Technique Versus Maitland Mobilization on Shoulder Pain and Disability
|
N/A | |
Terminated |
NCT03421951 -
Change in Pain and Quality of Life Following SCS for Chronic Pain
|
||
Recruiting |
NCT05834725 -
Resilience Coaching for Adolescents With Chronic Musculoskeletal Pain
|
N/A |